| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.008 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |